Citigroup’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,700
| Closed | -$34K | – | 7898 |
|
|
2020
Q4 | $34K | Hold |
1,700
| – | – | ﹤0.01% | 6316 |
|
|
2020
Q3 | $30K | Hold |
1,700
| – | – | ﹤0.01% | 5930 |
|
|
2020
Q2 | $46K | Sell |
1,700
-100
| -6% | -$2.76K | ﹤0.01% | 6079 |
|
|
2020
Q1 | $45K | Sell |
1,800
-400
| -18% | -$14.6K | ﹤0.01% | 6073 |
|
|
2019
Q4 | $115K | Sell |
2,200
-7,900
| -78% | -$362K | ﹤0.01% | 5649 |
|
|
2019
Q3 | $404K | Sell |
10,100
-40,800
| -80% | -$1.88M | ﹤0.01% | 4546 |
|
|
2019
Q2 | $2.43M | Buy |
50,900
+26,200
| +106% | +$1.06M | ﹤0.01% | 2632 |
|
|
2019
Q1 | $1.36M | Buy |
24,700
+16,300
| +194% | +$776K | ﹤0.01% | 3061 |
|
|
2018
Q4 | $306K | Sell |
8,400
-3,800
| -31% | -$156K | ﹤0.01% | 4610 |
|
|
2018
Q3 | $605K | Sell |
12,200
-13,600
| -53% | -$692K | ﹤0.01% | 4055 |
|
|
2018
Q2 | $1.14M | Buy |
25,800
+14,500
| +128% | +$598K | ﹤0.01% | 3218 |
|
|
2018
Q1 | $453K | Sell |
11,300
-20,300
| -64% | -$805K | ﹤0.01% | 4087 |
|
|
2017
Q4 | $1.27M | Buy |
+31,600
| New | +$1.21M | ﹤0.01% | 3111 |
|
Citigroup's ZGNX Position: Q1 2022 in Review
Citigroup sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 18,877 shares — an estimated $307K sold.
Citigroup first reported a position in ZGNX in Q2 2013 and held it in 35 quarters. The position peaked at $1.17M in Q4 2019. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- Citigroup reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- Citigroup sold 18,877 Zogenix, Inc. shares in Q1 2022, an estimated $307K.
- Citigroup first reported a position in Zogenix, Inc. in Q2 2013 and held it in 35 quarters.
- Citigroup's Zogenix, Inc. position peaked at $1.17M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on Citigroup's 13F filing for Q1 2022, filed 12 May 2022.